Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Hematologic Neoplasms × Hydroxychloroquine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Pancreatic Neoplasms 7 Colorectal Neoplasms 5 Prostatic Neoplasms 4 Breast Neoplasms 4 Neoplasms 3 COVID-19 3 Ovarian Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Non-Small-Cell Lung 2 Untreated Resectable Pancreatic Adenocarcinoma 1 Sarcoma 1 Rectal Neoplasms 1 Peripheral Nervous System Diseases 1 Pancreatic Cancer Resectable 1 Neoplasm, Residual 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia 1 Klatskin Tumor 1 Hypoxia 1 Hematologic Neoplasms 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Transitional Cell 1 Biliary Tract Neoplasms 1 Bile Duct Neoplasms 1 Adenocarcinoma of Lung 1

Interventions

Cyclophosphamide 34 fludarabine 29 Tacrolimus 25 Whole-Body Irradiation 22 Mycophenolic Acid 22 Busulfan 21 fludarabine phosphate 19 Melphalan 16 thymoglobulin 14 Antilymphocyte Serum 14 Thiotepa 11 Methotrexate 11 Stem Cell Transplantation 8 Sirolimus 7 Rituximab 7 Granulocyte Colony-Stimulating Factor 7 Filgrastim 6 trametinib 5 ruxolitinib 4 merphos 4 Nivolumab 4 Cytarabine 4 Cyclosporine 4 Cord Blood Stem Cell Transplantation 4 fedratinib 3 ceritinib 3 angiotensin I (1-7) 3 Radiotherapy 3 Peripheral Blood Stem Cell Transplantation 3 Pentostatin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04392128 2020-09-04

HYACINTHE

Institut de cancérologie Strasbourg Europe

Phase 2 Withdrawn

Other hematologic neoplasm

COVID-19, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡